Dr. John Clark Wilcox, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Dr. Mark David Jobman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Dr. Jeffrey John Muilenburg, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Alexis R. Erbst, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Dr. Timothy James Widhalm, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Jennifer C Harney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Dr. Scott Roger Johnson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3191 Fax: 402-694-2146 |
Dr. Michael John Sullivan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 O St, Aurora, NE 68818 Phone: 402-694-3171 Fax: 402-694-2146 |
News Archive
While there has been a lot of focus on the role of cannabis use in psychosis, there has been less attention on whether cannabis use is associated with an increased risk of common mental health disorders, such as depression and anxiety.
In a new study, researchers at the University of Pennsylvania School of Nursing's Center for Health Outcome and Policy Research and the Children's Hospital of Philadelphia examined the factors influencing the likelihood of missed nursing care in a pediatric setting.
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease.
CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the 2015 annual Scientific Sessions of the Heart Rhythm Society (HRS) in a Late-Breaking Clinical Trial Session. Results were presented by Dr. Michael Zile from the Medical University of South Carolina.
› Verified 7 days ago